Impact of dosing strategy on clinical outcomes of patients with lupus nephritis initially treated with lower-than-recommended-dose cyclophosphamide
For patients with LN initially treated with lower-than-recommended-dose cyclophosphamide, titration of the cyclophosphamide dose ≥0.5 g/m<sup>2</sup> was beneficial on renal response, while reducing infection leading to hospitalization and LN-associated death.
Authors
- Nutthapong Sunanthamethee
- Arunchai Chang (ORCID: https://orcid.org/0000-0002-0158-2685)
- Aniwat Choomnirat
- Sorawat Sangkaew (ORCID: https://orcid.org/0000-0002-1862-0879)
- Kittiphan Chienwichai (ORCID: https://orcid.org/0000-0002-6382-2656)
Institutions
- Hatyai Hospital (TH)
Publication Details
- Journal
- Heliyon
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e37359
- Citations
- 1
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.47